- Home
- PLAG vs HOOK Comparison
PLAG vs HOOK Comparison
Compare PLAG & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAG
- HOOK
- Stock Information
- Founded
- PLAG 1986
- HOOK 2011
- Country
- PLAG United States
- HOOK United States
- Employees
- PLAG N/A
- HOOK N/A
- Industry
- PLAG Packaged Foods
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- PLAG Consumer Staples
- HOOK Health Care
- Exchange
- PLAG Nasdaq
- HOOK Nasdaq
- Market Cap
- PLAG 8.2M
- HOOK 9.3M
- IPO Year
- PLAG N/A
- HOOK 2019
- Fundamental
- Price
- PLAG $2.60
- HOOK $1.56
- Analyst Decision
- PLAG
- HOOK Buy
- Analyst Count
- PLAG 0
- HOOK 4
- Target Price
- PLAG N/A
- HOOK $10.67
- AVG Volume (30 Days)
- PLAG 382.4K
- HOOK 166.9K
- Earning Date
- PLAG 06-17-2025
- HOOK 06-17-2025
- Dividend Yield
- PLAG N/A
- HOOK N/A
- EPS Growth
- PLAG N/A
- HOOK N/A
- EPS
- PLAG N/A
- HOOK N/A
- Revenue
- PLAG $6,066,143.00
- HOOK $9,351,000.00
- Revenue This Year
- PLAG N/A
- HOOK N/A
- Revenue Next Year
- PLAG N/A
- HOOK N/A
- P/E Ratio
- PLAG N/A
- HOOK N/A
- Revenue Growth
- PLAG N/A
- HOOK N/A
- 52 Week Low
- PLAG $0.85
- HOOK $0.72
- 52 Week High
- PLAG $5.52
- HOOK $8.50
- Technical
- Relative Strength Index (RSI)
- PLAG 63.95
- HOOK 56.94
- Support Level
- PLAG $2.47
- HOOK $1.51
- Resistance Level
- PLAG $3.15
- HOOK $1.65
- Average True Range (ATR)
- PLAG 0.37
- HOOK 0.14
- MACD
- PLAG 0.12
- HOOK -0.02
- Stochastic Oscillator
- PLAG 72.50
- HOOK 34.37
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.